Pricing

CinCor Pharma Inc (CINC)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Marc M. P. de Garidel
Employees:
20
230 THIRD AVE., 6TH FLOOR, WALTHAM, MA, 02451
8445311834
CinCor Pharma, Inc. engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteroni® and others. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available